Human Reproduction, Vol. 15, No. 1, 11-16,
January 2000
© 2000 European Society of Human Reproduction and Embryology
Urinary oestrogen patterns in long follicular phases
1 Department of Epidemiology, University of Michigan, Ann Arbor, Michigan 481092029, 2 Epidemiology Branch and 3 Biostatistics Branch, National Institute of Environmental Health Sciences, North Carolina, USA
| Abstract |
|---|
|
|
|---|
Long menstrual cycles have been associated with reduced risk of breast cancer and increased risk of osteoporosis. These observations have led to assumptions about the endogenous oestrogen exposure of women with long cycles. However, daily oestrogen profiles in long menstrual cycles have not been described. This paper examines daily urinary oestrogen profiles during the follicular phases of 416 conception and non-conception cycles. Women were aged 2142 years, had no history of infertility and were not under treatment. Twenty-eight cycles were defined as long, with a follicular phase that lasted 24 days or more. Five patterns were observed among these long cycles, the most common being a pattern consistent with delayed emergence of a dominant follicle. Other patterns were a pattern consistent with demise and replacement of a dominant follicle, one consistent with delayed follicular recruitment, one showing a prolonged initial drop in oestrogen and one with an extended oestrogen peak. Average follicular phase oestrogen concentrations were highest in cycles with short follicular phases (711 days). Oestrogen concentrations from long follicular phases (2459 days) did not differ substantially from follicular phases of usual length (1217 days). The oestrogen profiles in long follicular phases are heterogeneous and not necessarily hypo-oestrogenic.
Key words: follicular phase/menstrual cycle/oligomenorrhoea/urinary oestrone-3-glucuronide
| Introduction |
|---|
|
|
|---|
Associations have been described between long menstrual cycles and decreased risk of breast cancer and increased risk of osteoporosis (reviewed in Harlow and Ephross, 1995). Menstrual cycle length, in turn, is determined primarily by the rate and quality of follicular growth (Speroff et al., 1994
Harlow and Zeger (1991) proposed that long cycles in non-lactating women may result from delayed folliculogenesis (a lag between demise of the corpus luteum from the previous cycle and the start of gonadotrophin-dependent folliculogenesis). This process would be similar to the follicular suppression observed in many lactating women, who experience a delay in the onset of gonadotrophin-dependent folliculogenesis and recruitment of follicles. Faundes et al. (1996) more recently reported on the functional life span of the dominant follicle in cycles that were anovulatory due to administration of continuous low dose progesterone (Norplant). In this study, the lifespan of a follicle was relatively fixed once it emerged as dominant. This lifespan was unrelated to menstrual cycle length. They concluded that variation in the length of the menstrual cycle must therefore be due to variation in the duration of time to follicular recruitment (consistent with an hypothesis of follicular suppression) or to variation in the time to emergence of the dominant follicle once recruitment has occurred. Alternatively, long cycles may result from early death of a dominant follicle and its replacement (Hirschfield, 1997).
In order to explore the relationship between ovarian function and menstrual cycle length in non-lactating women, oestrogen profiles were examined for follicular phases of various lengths using daily urinary hormone data. We were specifically interested in whether the oestrogen patterns in long cycles are most consistent with (i) delayed follicular recruitment (ovarian suppression); (ii) prolonged time between recruitment and emergence of the dominant follicle; or (iii) repeated folliculogenesis due to early death of a dominant follicle.
| Materials and methods |
|---|
|
|
|---|
This paper is based on urinary hormone data collected as part of the North Carolina Early Pregnancy Study (NCEPS) (Wilcox et al., 1988
Oestrogen and progesterone metabolites [oestrone-3-glucuronide (E1G) and pregnanediol-3-glucuronide] were measured using radioimmunoassay (Samarajeewa et al., 1979
; Wilcox et al., 1987
). Oestrogen metabolite data were available for 724 cycles from 217 women. Seven cycles were unambiguously anovulatory and these cycles have been excluded (cycle lengths of 2853 days). A day of ovulation could be identified for 696 cycles. For a subset of about 40% of the cycles, assays were performed only for a mid-cycle window, so the full follicular phase oestrogen profile was not available. Follicular phases with no defined start day for the menstrual cycle, with no defined day of ovulation or with more than 5 days missing were excluded. This left 416 follicular phases, contributed by 167 women (one to eight cycles per woman). Conception occurred in 144 (35%) of these cycles, including subclinical conceptions that ended prior to clinical recognition.
Day of ovulation was estimated from the relative concentrations of urinary oestrogen and progesterone metabolites. This ratio drops rapidly around the time of ovulation, when oestrogen production falls and progesterone production increases as the follicle luteinizes. This marker has been validated against the urinary luteinizing hormone (LH) peak (Baird et al., 1991
) and appears to be as precise a marker of ovulation as estimates based on serum LH (Baird et al., 1995
). The follicular phase was defined as the first day of the cycle to the day before the estimated day of ovulation. Thus, in a cycle with ovulation on day 14, the follicular phase is 13 days.
Analysis
A long follicular phase was defined as a follicular phase of 24 days or longer, which is equal to the mean +1 SD (17.2 ± 6.7 days) of the follicular phase length distribution in the NCEPS study (Baird et al., 1995
). [As reviewed (Harlow and Ephross, 1995
), the mean in this data set is consistent with the mean in other studies that included long cycles but longer than that reported by studies that exclude long cycles and/or report a geometric mean. It is the latter studies that report the mean follicular phase length to be 13-15 days] This definition is consistent with previous literature on the length of extreme follicular phases (reviewed in Harlow and Ephross, 1995). If a luteal phase of 13 days is assumed (the mean luteal phase length observed in the NCEPS; Baird et al., 1991), plus the day of ovulation, this definition of a long follicular phase is roughly equivalent to having a menstrual cycle length of 38 days or more.
In order to evaluate how oestrogen patterns might vary across cycles with different follicular phase lengths, the oestrogen profiles of individual cycles were visually examined for selected follicular phases of various lengths. A random sample was selected of 30 follicular phases of 1315 days, all 24 follicular phases of 1920 days, and all 28 long follicular phases (24 days or longer). The E1G pattern in each case was smoothed using a 3 day moving average. All cycles were also categorized by follicular phase length (711 days, 1217 days, 1823 days and 2459 days with n = 77, 230, 81 and 28 respectively) and the daily geometric mean E1G values were graphed, with reference to the day of ovulation.
The oestrogen pattern during a typical follicular phase of length approximately 14 days is a slow rise followed by a more rapid rise just before ovulation (van Santbrink et al., 1995
). The oestrogen profile of each follicular phase was statistically summarized using a bent stick regression model (Neter and Wasserman, 1974
). Essentially, this linear two phase regression model estimates one slope for a portion of the time scale and a second slope beyond some change point, with this change point being estimated from the data. The first segment typically captured the early-to-mid-follicular slow oestrogen rise. The second segment typically bent upward to capture the late-follicular rapid rise prior to ovulation. The fit is optimized by minimizing the sum of squared differences between the observations and the bent line. The first few days of a cycle often show a pattern of declining oestrogen from the end of the previous luteal phase. These days were excluded by beginning the regression analysis with the day after the early drop in urinary oestrogen. The regression analysis was concluded at the mid-cycle peak of urinary oestrogen. As these slopes were calculated for each individual cycle, this analysis procedure was applied only to follicular phases with no more than 10% missing data (n = 316). The average early slope for follicular phases of various lengths was then calculated and these were compared using a generalized linear mixed models approach (SAS procedure PROC MIXED) in order to account for repeated observations within the same woman. Averages of the later slopes were compared similarly across the four categories of follicular phase length as were average number of days from the start of the rapid rise until the day of ovulation.
It is commonly assumed that women with long cycles have reduced exposure to endogenous oestrogen. The amount of oestrogen exposure was evaluated during the follicular phase, stratifying by follicular phase length. The mean daily E1G concentration was calculated for each cycle for the entire follicular phase and also for the period of the slow rise (to estimate average oestrogen concentrations with and without the oestrogen peak). The distributions of the E1G concentrations were plotted for the four phase length categories (711 days, 1217 days, 1823 days and 2459 days).
| Results |
|---|
|
|
|---|
Table I
|
Figure 1
|
When smoothed daily oestrogen profiles were examined for individual follicular phases of length 1315 days, the oestrogen pattern generally followed the expected profile. In every case, urinary oestrogen concentrations either dropped slightly or were flat for the first 24 days, rose slowly for subsequent 610 days, and then rose sharply for 25 days, after which they peaked and dropped. Cycles with long follicular phases followed a similar overall pattern but one or more of the various components were lengthened. The patterns were categorized as follows: low-flat: oestrogen concentrations remained low and flat for an extended interval; extended slow rise: the initial slow rise in oestrogen occurred over an extended interval and the pattern of rise was either fairly linear or somewhat erratic with slight rises and falls in oestrogen concentrations; multiple peaks: a series of rapid rises followed by falls; extended peak: the E1G peak was elevated for more than 10 days; extended initial drop: the decline in oestrogen at the start of the cycle occurred over an extended interval of time (7 days or longer).
Figure 2
presents typical examples of each type of long follicular phase. The most common pattern among the long cycles was the extended slow rise which occurred in more than half of the observed follicular phases. The other four long patterns were infrequent.
|
Women who contributed more than one long follicular phase did not necessarily repeat the same hormone pattern. Of the eight women who contributed two long cycles to this analysis, six women had both cycles classified as an extended slow rise. One woman had an extended slow rise and a low-flat pattern. One woman had an extended slow rise and an extended peak.
Table II
shows the mean slope and SE for the slow and acute rise in E1G values by the four categories of follicular phase length. The slope for the slow rise in the shortest follicular phases (711 days) was considerably steeper on average and more variable than the slope of the slow rise in 1217 day or longer follicular phases. The slope of the slow rise declined with length of the follicular phase (P value = 0.0001). In contrast, the slopes during the rapid rise were not significantly different by length of the follicular phase (P value = 0.27). The time from the start of the rapid rise until the day of ovulation increased slightly with length of the follicular phase with the mean (SE) being 2.98 (0.34), 3.91 (0.17), 4.21 (0.25) and 4.95 (0.42) days for follicular phases of 711, 1217, 1823 and 2459 days respectively.
|
Oestrogen concentrations in long cycles with an extended slow rise or with multiple peaks were often substantial. When the distributions of the average daily concentrations of E1G were evaluated by follicular phase length (Figure 3
|
|
| Discussion |
|---|
|
|
|---|
Menstrual cycle length is easily measured, but the hormonal patterns that underlie cycle length are much more difficult to assess. The few long series of daily hormonal data that are available come from women with lactational amenorrhoea. Those data demonstrate heterogeneity, but the majority of the women appear to experience extended periods of low oestrogen production (Shaaban et al., 1987
Most of the long follicular phases in this study showed a prolonged initial slow rise in oestrogen. The initial slow rise began early in the cycle, as also seen in follicular phases of 1315 days, but this slow rise continued well beyond the usual 510 days. It is postulated that this prolonged slow rise may reflect delay in emergence of a dominant follicle. Concentrations of the oestrogen metabolite in this pattern were often relatively high.
Two other patterns were also observed, although infrequently: an extended oestrogen peak and a prolonged initial drop. An extended peak may be due to the presence of an ovarian cyst. The prolonged initial drop followed an anovulatory cycle in some instances. Follicular phases whose lengths were only moderately long (i.e., 1823 days), exhibited the same heterogeneity observed in the long cycles. Consistent with this heterogeneity of patterns, concentrations of the excreted oestrogen metabolite also varied in both long and moderately long follicular phases.
It was concluded previously that most of the variation in menstrual cycle length reflects differences in the duration of follicle recruitment and selection (Faundes et al., 1996
), which is consistent with the findings of this study. Their observations of the lifespan of the dominant follicle were among cycles of women under continuous low-dose progesterone administration. The data presented here are also consistent with human ultrasound data (Gore et al., 1995
). They observed multiple large follicles (
8 mm in diameter) present during any given ovulatory cycle, several of which may have the potential to attain dominance. The follicle that ovulated was often not the first large follicle to be identified. They also found that once a follicle became dominant, it grew rapidly. If a dominant follicle showed arrested growth, it became atritic and was replaced by another. They concluded that successful emergence from the pool of large follicles requires precise conditions and timing. They postulated that when larger numbers of follicles are recruited, more time will elapse before a single follicle emerges as dominant.
One of the important clinically-recognized causes of oligomenorrhoea is polycystic ovaries (PCO) (Adams et al., 1986
; Botsis et al., 1995
). It was demonstrated (Van der Meer et al., 1998
) that women with polycystic ovaries have larger cohorts of follicles sensitive to follicle stimulating hormone (FSH) and thus any individual follicle may have a more difficult time establishing dominance (Gore et al., 1997
). There appear to be no studies reporting daily oestrogen profiles in women with PCO. None of the women in this study was diagnosed with PCO, but undiagnosed PCO could nonetheless have contributed to some of the patterns observed.
Several studies have examined menstrual cycle length in relation to breast cancer (Henderson et al., 1985
; Garland et al., 1998
; Whelan et al., 1994
) with the assumption that cycle length is a surrogate for hormonal exposure. Other studies have demonstrated associations between follicular phase length and reproductive endpoints such as sex ratio (James, 1995
; Weinberg et al., 1995
), contralateral ovulation and pre-embryo development (Fukada et al., 1998
). When the average amount of exposure to endogenous oestrogen in the follicular phase was examined, as measured by the major urinary metabolite E1G, women with the shortest follicular phases had the highest mean follicular oestrogen concentration. Follicular phases that were usual in length, moderately long or long were similar in their mean follicular E1G concentrations. It appears that women with short cycles may have higher oestrogen exposure both because mid-cycle oestrogen peaks occur more frequently and because the early and mid-follicular phase concentrations are higher in short cycles.
When information about menstrual cycles are obtained only by self report of bleeding using menstrual diaries, other hormonal patterns would also occur among the long cycles. For example, some anovulatory cycles may also be included. Three of the seven anovulatory cycles in the NCEPS were >38 days in length. Two of these anovulatory cycles had low oestrogen throughout the cycle, while the third had moderately high concentrations. Another possibility is the occurrence of what are referred to as `double cycles'. In the data reported here, four diary-reported menstrual cycles of >38 days actually showed hormonal patterns of two ovulatory cycles with no reported menstruation in between. Whether this phenomenon reflects reporting error or suppression of menstrual flow (Strassman, 1996
) is unknown; however, such `double' cycles do not show reduced follicular oestrogen excretion.
This study has limitations. Observations were drawn from a group of self-selected volunteers, although none had any fertility problems. Daily oestrogen profiles were characterized by a single urinary oestrogen metabolite that varies among women in the accuracy with which it reflects total oestrogen production and in how well it corresponds to circulatory concentrations. Data on daily FSH concentrations is also lacking. As many of these cycles resulted in pregnancy, this data set does not lend itself to examining the relationship between follicular phase oestrogen patterns and luteal-phase length. Finally, this is an analysis of cycles and not of women. It is not known how these results might compare to long cycles in women with clinically diagnosed oligomenorrhoea. While these limitations should be kept in mind, there appears to be no other description of oestrogen patterns in long follicular phases of healthy, untreated, non-lactating women.
In summary, the daily oestrogen profile in long cycles is heterogeneous. Although some cycles show a pattern consistent with follicular suppression, the most common pattern underlying the long follicular phases in women in the NCEPS appears to be prolongation of the time from recruitment to emergence of a dominant follicle. Given the apparent heterogeneity of oestrogen patterns associated with long follicular phases, caution is advised in assuming that long cycles reduce a woman's average amount of endogenous exposure to unopposed oestrogens. Whether this conclusion also applies to women with clinically diagnosed oligomenorrhoea requires further investigation. Additional studies of daily oestrogen profiles in women with oligomenorrhoea are warranted, as are studies in women with amenorrhoea and women with polycystic ovaries. Subsequent studies would benefit by inclusion of a more ethnically diverse sample, daily measures of gonadotrophins, concurrent sonographic data, and a sample size adequate to evaluate age effects more precisely.
| Acknowledgments |
|---|
This research was supported in part by a grant from the National Institute of Child Health and Human Development (HD30373). Joy Pierce managed the field study of women attempting pregnancy and, assisted by Francis Patterson and Irene Gunter, managed urine storage and shipment. Paul Musey and Delwood Collins were responsible for laboratory assays assisted by Robin Randall and Michele Mason-Woodard. We would like to thank D.R.McConnaughey for his assistance with statistical analyses and graphics and John Randolph, Glinda Cooper and Freja Kamel who read an earlier draft of this manuscript.
| Notes |
|---|
4 To whom correspondence should be addressed
| References |
|---|
|
|
|---|
Adams, J., Polson, D.W. and Franks, S. (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br. Med. J., 293, 355359.
Baird, D.D., McConnaughey, D.R., Weinberg, C.R. et al. (1995) Application of a method for estimating day of ovulation using urinary estrogen and progesterone metabolites. Epidemiology, 6, 547550.[Web of Science][Medline]
Baird, D.D., Weinberg, C.R., Wilcox, A.J. et al. (1991) Using the ratio of urinary oestrogen and progesterone metabolites to estimate day of ovulation. Stat. Med., 10, 255266.[Web of Science][Medline]
Botsis, D., Kassanos, D., Pyrgiotis, E. and Zourlas, P.A. (1995) Sonographic incidence of polycystic ovaries in a gynecological population. Ultrasound Obstet. Gynecol., 6, 182185.[Web of Science][Medline]
Burger, H.G., Catt, K.J. and Brown, J.B. (1968) Relationship between plasma luteinizing hormone and urinary oestrogen excretion during the menstrual cycle. J. Clin. Endocrinol., 28, 15081512.
Faundes, A., Brache, V. and Alvarez, F. (1996) Functional life-span of the dominant follicle in pharmacologically induced anovulatory cycles. Hum. Reprod., 11, 114116.
Fukada, M., Fukada, K., Anderson, C.Y. et al. (1998) Contralateral ovulation shortens follicular phase length and favours pre-embryo development during ovarian stimulation with clomiphene citrate. Hum. Reprod., 13, 15901594.
Garland, M., Hunter, D.J. Colditz, G.A. et al. (1998) Menstrual cycle characteristics and history of ovulatory infertility in relation to breast cancer risk in a large cohort of US women. Am. J. Epidemiol., 147, 636643.
Gore, M.A., Nayudu, P.L., Vlaisavljevic, V. et al. (1995) Prediction of ovarian cycle outcome by follicular characteristics, stage 1. Hum. Reprod., 10, 23132319.
Gore, M.A., Nayudu, P.L. and Vlaisavljevic, V. (1997) Attaining dominance in vivo: distinguishing dominant from challenger follicles in humans. Hum. Reprod., 12, 27412747.
Harlow, S.D. and Ephross, S.A. (1995) Epidemiology of menstruation and its relevance to women's health. Epidemiol. Rev., 17, 265286.
Harlow, S.D. and Zeger, S.L. (1991) An application of longitudinal methods to the analysis of menstrual diary data. J. Clin. Epidemiol., 44, 10151025.[Web of Science][Medline]
Henderson, B.E., Ross, R.K., Judd, H.L. et al. (1985) Do regulatory ovulatory cycles increase breast cancer risk? Cancer, 56, 12061208.[Web of Science][Medline]
Hirshfield, A.N. (1997) Overview of ovarian follicular development: considerations for the toxicologist. Environ. Mol. Mutagen., 29, 1015.[Web of Science][Medline]
James, W.H. (1995) Follicular phase length, cycle day of conception and sex ratio of offspring. Hum. Reprod., 10, 25292531.
Landgren, B.M., Unden, A.L. and Diczfalusy, E. (1980) Hormonal profile of the cycle in 68 normally menstruating women. Acta Endocrinol., 94, 8998.
Lenton, E.A., Landgren, B.M., Sexton, L. et al. (1984) Normal variation in the length of the follicular phase of the menstrual cycle: effect of chronological age. Br. J. Obstet. Gynaecol., 91, 681684.[Web of Science][Medline]
Matsumoto, S., Nogami, Y. and Ohkuri, S. (1962) Statistical studies on menstruation: a criticism on the definition of normal menstruation. Gunma J. Med. Sci., 11, 294318.
Neter, J. and Wasserman, W. (1974) Applied linear statistical models. Irwin, Chicago.
Samarajeewa, P., Cooley, G. and Kellie, A.E. (1979) The radioimmunoassay of pregnanediol-3
-glucuronide. J. Steroid. Biochem., 11, 11651171.[Web of Science][Medline]
Shaaban, M.M., Sayed, G.H. and Ghaneimah, S.A. (1987) The recovery of ovarian function during breast-feeding. J. Steroid. Biochem., 27, 10431052.[Web of Science][Medline]
Speroff, L., Glass, R.H. and Kase, N.G. (1994) Clinical gynecologic endocrinology and infertility, 5th edn. Williams and Wilkins, Baltimore.
Strassman, B. (1996) The evolution of endometrial cycles and menstruation. Quarterly Review of Biology, 71, 181220.[Medline]
Van der Meer, M., Hompes, P.G.A., De Boer, J.A.M. et al. (1998) Cohort size rather than follicle-stimulating hormone threshold concentration determines ovarian sensitivity in polycystic ovary syndrome. J. Clin. Endocrinol. Metabol., 83, 423426.
van Santbrink, E.J.P., Hop, W.C., Van Dessel, T.J.H.M. et al. (1995) Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. Fertil. Steril., 64, 3743.[Web of Science][Medline]
Vollman, R.F. (1977) The menstrual cycle. Saunders, Philadelphia.
Weinberg, C.R., Baird, D.D. and Wilcox, A.J. (1995) The sex of the baby may be related to the length of the follicular phase in the conception cycle. Hum. Reprod., 10, 304307.
Whelan, E.A., Sandler, D.P., Root, J.L. et al. (1994) Menstrual cycle patterns and risk of breast cancer. Am. J. Epidemiol., 140, 10811090.
Wilcox, A.J., Baird, D.D., Weinberg, C.R. et al. (1987) The use of biochemical assays in epidemiologic studies of reproduction. Environ. Health Perspect., 75, 2935.[Web of Science][Medline]
Wilcox, A.J., Weinberg, C.R., O'Connor, J.F. et al. (1988) Incidence of early loss of pregnancy. N. Engl. J. Med., 319, 189194.[Abstract]
World Health Organization (1983) Task force on methods for the determination of the fertile period. A prospective multicentre trial of the ovulation method of natural family planning. III. Characteristics of the menstrual cycle and of the fertile phase. Fertil. Steril., 40, 773778.[Web of Science][Medline]
Submitted on February 10, 1999; accepted on August 26, 1999.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G.-Q. Tang, S. Paratkar, and S. S. Patel Fluorescence Mapping of the Open Complex of Yeast Mitochondrial RNA Polymerase J. Biol. Chem., February 27, 2009; 284(9): 5514 - 5522. [Abstract] [Full Text] [PDF] |
||||
![]() |
H M Picton, S E Harris, W Muruvi, and E L Chambers The in vitro growth and maturation of follicles Reproduction, December 1, 2008; 136(6): 703 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Khoureiry, S Ibala-Rhomdane, L Mery, T Blachere, J-F Guerin, J Lornage, and A Lefevre Dynamic CpG methylation of the KCNQ1OT1 gene during maturation of human oocytes J. Med. Genet., September 1, 2008; 45(9): 583 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Segers, T. Adriaenssens, W. Coucke, R. Cortvrindt, and J. Smitz Timing of Nuclear Maturation and Postovulatory Aging in Oocytes of In Vitro-Grown Mouse Follicles with or Without Oil Overlay Biol Reprod, May 1, 2008; 78(5): 859 - 868. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. X. Yeo, R. B. Gilchrist, J. G. Thompson, and M. Lane Exogenous growth differentiation factor 9 in oocyte maturation media enhances subsequent embryo development and fetal viability in mice Hum. Reprod., January 1, 2008; 23(1): 67 - 73. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-S. Hyun, J.-H. Cha, W.-Y. Son, S.-H. Yoon, K.-A. Kim, and J.-H. Lim Optimal ICSI timing after the first polar body extrusion in in vitro matured human oocytes Hum. Reprod., July 1, 2007; 22(7): 1991 - 1995. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Meyer, S. L. Zeger, S. D. Harlow, M. Sowers, S. Crawford, J. L. Luborsky, I. Janssen, D. S. McConnell, J. F. Randolph, and G. Weiss Characterizing Daily Urinary Hormone Profiles for Women at Midlife Using Functional Data Analysis Am. J. Epidemiol., April 15, 2007; 165(8): 936 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, F. F. Kadlubar, and J. Z. Chen DNA supercoiling suppresses real-time PCR: a new approach to the quantification of mitochondrial DNA damage and repair Nucleic Acids Res., March 13, 2007; (2007) gkm010v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jacobs, M. Gerards, P. Chinnery, J. Dumoulin, I. de Coo, J. Geraedts, and H. Smeets mtDNA point mutations are present at various levels of heteroplasmy in human oocytes Mol. Hum. Reprod., March 1, 2007; 13(3): 149 - 154*. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kameyama, F. Filion, J. G. Yoo, and L. C Smith Characterization of mitochondrial replication and transcription control during rat early development in vivo and in vitro Reproduction, February 1, 2007; 133(2): 423 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Spikings, J. Alderson, and J. C. St. John Regulated Mitochondrial DNA Replication During Oocyte Maturation Is Essential for Successful Porcine Embryonic Development Biol Reprod, February 1, 2007; 76(2): 327 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Howards, I. Hertz-Picciotto, C. R. Weinberg, and C. Poole Misclassification of Gestational Age in the Study of Spontaneous Abortion Am. J. Epidemiol., December 1, 2006; 164(11): 1126 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Berdanier Mitochondrial gene expression: influence of nutrients and hormones. Experimental Biology and Medicine, November 1, 2006; 231(10): 1593 - 1601. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Small, M. Marcus, S. L. Sherman, A. K. Sullivan, A. K. Manatunga, and H. S. Feigelson CYP17 genotype predicts serum hormone levels among pre-menopausal women Hum. Reprod., August 1, 2005; 20(8): 2162 - 2167. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Oehninger Strategies for Fertility Preservation in Female and Male Cancer Survivors Reproductive Sciences, May 1, 2005; 12(4): 222 - 231. [Abstract] [PDF] |
||||
![]() |
X. Shen, S. Zheng, V. Thongboonkerd, M. Xu, W. M. Pierce Jr., J. B. Klein, and P. N. Epstein Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E896 - E905. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Kelly and R. C. Scarpulla Transcriptional regulatory circuits controlling mitochondrial biogenesis and function Genes & Dev., February 15, 2004; 18(4): 357 - 368. [Full Text] [PDF] |
||||
![]() |
J. J. Faith and D. D. Pollock Likelihood Analysis of Asymmetrical Mutation Bias Gradients in Vertebrate Mitochondrial Genomes Genetics, October 1, 2003; 165(2): 735 - 745. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jazayeri, A. Andreyev, Y. Will, M. Ward, C. M. Anderson, and W. Clevenger Inducible Expression of a Dominant Negative DNA Polymerase-gamma Depletes Mitochondrial DNA and Produces a rho 0 Phenotype J. Biol. Chem., March 7, 2003; 278(11): 9823 - 9830. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Meyer and A. von Haeseler Identifying Site-Specific Substitution Rates Mol. Biol. Evol., February 1, 2003; 20(2): 182 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Rosenbusch, M. Schneider, B. Glaser, and C. Brucker Cytogenetic analysis of giant oocytes and zygotes to assess their relevance for the development of digynic triploidy Hum. Reprod., September 1, 2002; 17(9): 2388 - 2393. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Williams Another Surprise from the Mitochondrial Genome N. Engl. J. Med., August 22, 2002; 347(8): 609 - 612. [Full Text] [PDF] |
||||
![]() |
M.G. Katz, A.O. Trounson, and D.S. Cram DNA fingerprinting of sister blastomeres from human IVF embryos Hum. Reprod., March 1, 2002; 17(3): 752 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Alper, P. Brinsden, R. Fischer, and M. Wikland To blastocyst or not to blastocyst? That is the question Hum. Reprod., April 1, 2001; 16(4): 617 - 619. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


















